Beneficient Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Beneficient (Nevada corporation) on April 7, 2025, reporting events occurring on April 4, 2025. The filing details a primary capital transaction involving the issuance of unregistered equity securities and the amendment of the Company's Articles of Incorporation to designate a new series of preferred stock.
Key Financial Metrics and Transaction Details
- Transaction Value: The Company closed a primary capital transaction with a net asset value of $9.6 million.
- Securities Issued: 965,576 shares of Series B-6 Resettable Convertible Preferred Stock were issued to a customer.
- Consideration: In exchange for the preferred stock, the Company's customized trust vehicles acquired a limited partner interest in an investment fund.
- Conversion Terms: The Series B-6 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.3151 per share.
- Maximum Dilution: Up to 40,862,294 shares of Class A Common Stock may be issued upon full conversion of the Series B-6 Preferred Stock.
- Financial Performance: The filing does not provide specific revenue, profit, cash flow, or debt metrics for the reporting period.
Material Changes and Security Terms
The filing discloses the creation of the Series B-6 Preferred Stock with the following material terms:
- Resettable Conversion Price: The conversion price resets monthly to the five-day trailing volume-weighted average price of the Class A Common Stock, subject to a floor of $0.2363 (75% of the initial price) and a cap at the initial price.
- Mandatory Conversion: Shares will automatically convert on the fifth anniversary of issuance or earlier if a resale registration statement becomes effective, subject to beneficial ownership limitations (4.99%) and Nasdaq exchange caps.
- Ranking: The stock ranks pari passu with Class A Common Stock regarding dividends and liquidation, but is junior to Series A and Series B-1 through B-5 preferred stock, and junior to all indebtedness.
- Voting Rights: Holders generally do not have voting rights except as required by law.
Outlook, Risks, and Contingencies
The Company notes that the issuance of Class A Common Stock upon conversion of the Series B-6 Preferred Stock is subject to requisite stockholder approval. A proxy statement will be filed to solicit this approval. The filing includes standard forward-looking statement disclaimers, noting that actual results may differ due to risks outlined in the Company's most recent Form 10-K and 10-Q. The securities were issued under Section 4(a)(2) of the Securities Act and Regulation D exemptions.
Investor Verification Checklist
- Verify the upcoming proxy statement for details on the stockholder vote required to approve the conversion of Series B-6 Preferred Stock.
- Review the Certificate of Designation (Exhibit 3.1) for complete terms regarding the monthly reset mechanism and conversion caps.
- Assess the potential dilution impact of up to 40.86 million shares of Class A Common Stock becoming issuable.
- Confirm the Company's compliance with Nasdaq listing rules regarding the "Exchange Cap" on share issuance.
- Check the most recent Form 10-K and 10-Q for updated liquidity and debt positions, as this 8-K does not contain financial statements.